OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

83 hedge funds and large institutions have $155M invested in Osiris Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$976K
Puts
$5.15M
Net Calls
Net Calls Change

Top Buyers

1 +$3.08M
2 +$1.89M
3 +$1.75M
4
OAM
Oxford Asset Management
United Kingdom
+$1.42M
5
Morgan Stanley
Morgan Stanley
New York
+$1.08M

Top Sellers

1 -$8.37M
2 -$1.52M
3 -$299K
4
Citigroup
Citigroup
New York
-$231K
5
BBA
Baker Bros. Advisors
New York
-$201K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$664K
27
$623K
28
$612K
29
$608K
30
$606K
31
$551K
32
$527K
33
$520K
34
$500K
35
$485K
36
$476K
37
$462K
38
$412K
39
$392K
40
$387K
41
$379K
42
$360K
43
$356K
44
$334K
45
$299K
46
$299K
47
$283K
48
$271K
49
$245K
50
$241K